Terug
Dagbereik
€ 1,81
€ 1,90
52-Weeksbereik
€ 0,62
€ 2,29
Volume
9.000
50D / 200D Gem.
€ 1,91
/
€ 1,58
Vorige Slotkoers
€ 1,81
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -6,4 | 0,4 |
| P/B | 1,0 | 2,9 |
| ROE % | -14,0 | 3,7 |
| Net Margin % | -23455,7 | 3,9 |
| Rev Growth 5Y % | -56,2 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
-€ 0,37
-€ 0,37 – -€ 0,37
|
39 M | 1 |
| FY2026 |
€ 0,90
€ 0,90 – € 0,90
|
1,3 B | 1 |
Belangrijkste Punten
Revenue declined -56,24% annually over 5 years
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -343,73M
Revenue growth is decelerating — 1Y growth trails 5Y average by 41,49%
Capital intensive — 167,42% of revenue goes to capex
Groei
Revenue Growth (5Y)
-56,24%
Revenue (1Y)-97,73%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-13,97%
ROIC-11,23%
Net Margin-23455,65%
Op. Margin-23025,64%
Veiligheid
Debt / Equity
0,00
Current Ratio12,88
Interest Coverage0,00
Waardering
P/E Ratio
-6,35
P/B Ratio0,97
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -97,73% | Revenue Growth (3Y) | -84,60% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -56,24% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,28M | Net Income (TTM) | -300,94M |
| ROE | -13,97% | ROA | -14,16% |
| Gross Margin | 57,29% | Operating Margin | -23025,64% |
| Net Margin | -23455,65% | Free Cash Flow (TTM) | -343,73M |
| ROIC | -11,23% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 12,88 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -6,35 | P/B Ratio | 0,97 |
| P/S Ratio | 1488,83 | PEG Ratio | -0,04 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,91B | Enterprise Value | 1,05B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1,28M | 56,60M | 54,09M | 76,88M | 35,00M |
| Net Income | -300,94M | -144,72M | -314,84M | -199,02M | -209,24M |
| EPS (Diluted) | -0,30 | -0,13 | -0,29 | -0,18 | -0,20 |
| Gross Profit | 735.000,0 | 25,99M | -24,69M | 39,17M | -23,50M |
| Operating Income | -295,42M | -300,21M | -343,98M | -224,97M | -217,11M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 2,12B | 2,49B | 2,66B | 2,83B | 3,07B |
| Total Liabilities | 158,41M | 148,94M | 117,16M | 100,89M | 85,42M |
| Shareholders' Equity | 1,97B | 2,34B | 2,54B | 2,73B | 2,98B |
| Total Debt | 7,63M | 8,42M | 4,24M | 2,75M | 1,59M |
| Cash & Equivalents | 865,73M | 330,12M | 2,47B | 2,50B | 2,71B |
| Current Assets | 1,97B | 2,33B | 2,54B | 2,63B | 2,83B |
| Current Liabilities | 153,05M | 140,68M | 108,19M | 90,97M | 73,77M |